Warning against Use in Teenagers Should Be Removed from Tamiflu’s Package Insert: MHLW Panel

MHLW drug safety panel meeting on May 16 A health ministry panel agreed to have a statement withdrawn from the package insert of the anti-influenza drug Tamiflu (oseltamivir) that its use should generally be avoided in teenage patients. The decision...read more